National Trials QA Team, Mount Vernon Hospital, Northwood, UK.
Clin Oncol (R Coll Radiol). 2012 Oct;24(8):e100-5. doi: 10.1016/j.clon.2012.06.010. Epub 2012 Jul 12.
To examine the effect of UK breast radiotherapy trials on the adoption of new radiotherapy techniques over the last 15 years.
The data were taken from questionnaires returned to the national radiotherapy quality assurance team for each of the major trials (START, Supremo, FAST, IMPORT) with additional information sought from heads of radiotherapy physics departments where needed.
The peak years for the introduction of three-dimensional radiotherapy corresponded to the opening of new trials requiring these techniques. Some non-trial centres had still not implemented three-dimensional techniques for breast cancer patients at the time the most recent questionnaire was completed (2009).
Clinical trials provide the framework and impetus for introducing more accurate radiotherapy for UK women with early breast cancer.
研究过去 15 年中英国乳腺癌放疗试验对新放疗技术采用的影响。
数据取自各主要试验(START、Supremo、FAST、IMPORT)的全国放疗质量保证团队返回的调查问卷,必要时向放疗物理部门负责人寻求额外信息。
三维放疗的引入高峰期与需要这些技术的新试验的开始时间相对应。在最近一次问卷调查完成时(2009 年),一些非试验中心的乳腺癌患者仍未采用三维技术。
临床试验为英国早期乳腺癌女性引入更精确放疗提供了框架和动力。